Full name
"PHARM POINT" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
41 - Construction work related to the construction of residential and non-residential buildings
42 - Works related to the construction of civil engineering and water engineering objects
43 - Specialized construction works
46.45.Z - Wholesale trade of perfumes and cosmetics
47.74.Z - Retail sale of medical and orthopedic products
52 - Warehousing, storage, and support activities for transport
64.92.Z - Other forms of credit granting
71 - Architectural and engineering activities, technical testing and analysis
77 - Rental and leasing
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -35,4 | -31,3 | 0 | 100 |
EBITDA | -10,1 | -15,2 | 0 | 100 |
Short time liabilities | 277,5 | 131,2 | 131,2 | 0 |
Equity capital | 289,8 | 258,5 | 258,5 | 0 |
Operating profit (EBIT) | -10,1 | -15,2 | 0 | 100 |
Assets | 650,1 | 389,7 | 389,7 | 0 |
Net profit (loss) | -35,4 | -31,3 | 0 | 100 |
Cash | 7,7 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 360,3 | 131,2 | 131,2 | 0 |
Net income from sale | 0 | 14 | 0 | -100 |
Working assets | 193,9 | 13 | 13 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -12,2 | -12,1 | 0 | 12,1 |
Equity capital to total assets | 44,6 | 66,3 | 66,3 | 0 |
Gross profit margin | -223,4 | 485,7 | ||
EBITDA Margin | -108,4 | 119,7 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 3422 | 2 147 483 648 | 2 147 480 226 |
Current financial liquidity indicator | 0.6988283395767212 | 0.09904894232749939 | 0.09904894232749939 | 0 |
Net dept to EBITDA | -29.112579345703125 | -5.204221248626709 | 23,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane